|
US5521297A
(en)
*
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
|
ES2308779T3
(es)
*
|
1995-07-26 |
2008-12-01 |
Astrazeneca Ab |
Receptores quimericos y metodos para identificar compuestos activos en los receptores de glutamato metabotropico y el uso de tales compuestos en el tratamiento de trastornos y enfermedades neurologicas.
|
|
US6221609B1
(en)
|
1996-07-03 |
2001-04-24 |
Eli Lilly And Company |
Isolate nucleic acid encoding human MGLUR8
|
|
US7262280B1
(en)
|
1998-04-03 |
2007-08-28 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and constructs encoding same
|
|
CA2325334A1
(en)
*
|
1998-04-03 |
1999-10-14 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and chimeric gabab receptors
|
|
EP1662255A3
(en)
*
|
1998-08-18 |
2006-09-13 |
The Johns Hopkins University School Of Medicine |
Homer interacting proteins
|
|
AU772105B2
(en)
*
|
1998-08-18 |
2004-04-08 |
Johns Hopkins University School Of Medicine, The |
Homer interacting proteins
|
|
IL141691A0
(en)
*
|
1998-08-31 |
2002-03-10 |
Trinity College Dublin |
Polypeptides and polynucleotides from coagulase-negative staphylococci
|
|
US20030166554A1
(en)
*
|
2001-01-16 |
2003-09-04 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US20030185754A1
(en)
*
|
2001-01-16 |
2003-10-02 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US6620850B2
(en)
*
|
2001-09-19 |
2003-09-16 |
University Of Florida |
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
|
|
WO2003054167A2
(en)
*
|
2001-12-20 |
2003-07-03 |
Merck & Co., Inc. |
Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
|
|
US7015195B2
(en)
*
|
2002-01-10 |
2006-03-21 |
Osteotrophin, Llc |
Treatment of bone disorders with skeletal anabolic drugs
|
|
WO2004050858A2
(en)
*
|
2002-12-04 |
2004-06-17 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to colon specific genes and proteins
|
|
US20050186658A1
(en)
*
|
2003-10-17 |
2005-08-25 |
Nps Pharmaceuticals, Inc. |
Chimeric metabotropic glutamate receptors and uses thereof
|
|
WO2005073730A1
(en)
*
|
2004-01-31 |
2005-08-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 8 (mglur8)
|
|
ATE540048T1
(de)
*
|
2004-10-14 |
2012-01-15 |
Carnegie Inst Of Washington |
Neurotransmittersensoren und verfahren zu ihrer verwendung
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
|
US8889950B2
(en)
*
|
2006-07-28 |
2014-11-18 |
The George Washington University |
Repression of AtGLR3.2 increases plant biomass
|
|
US7424876B2
(en)
*
|
2006-10-06 |
2008-09-16 |
Ford Global Technologies, Llc |
Pushrod engine with multiple independent lash adjusters for each pushrod
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TWI445532B
(zh)
|
2007-09-14 |
2014-07-21 |
Janssen Pharmaceuticals Inc |
1’,3’-二取代-4-苯基-3,4,5,6-四氫-2h,1’h-〔1,4’〕聯吡啶基-2’-酮化物
|
|
WO2009079566A2
(en)
*
|
2007-12-18 |
2009-06-25 |
Acumen Pharmaceuticals, Inc. |
Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
WO2010011404A2
(en)
|
2008-05-20 |
2010-01-28 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
ES2439291T3
(es)
|
2008-09-02 |
2014-01-22 |
Janssen Pharmaceuticals, Inc. |
Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
|
|
CA2744138C
(en)
|
2008-11-28 |
2015-08-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
SI2430022T1
(sl)
|
2009-05-12 |
2014-04-30 |
Janssen Pharmaceuticals, Inc. |
1,2,3-triazolo(4,3-a)piridin derivati in njihova uporaba za zdravljenje ali prepreäśevanje nevroloĺ kih in psihiatriäśnih nepravilnosti
|
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
WO2012062751A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
WO2012062759A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
KR20220051273A
(ko)
|
2014-01-21 |
2022-04-26 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
|
IL279202B2
(en)
|
2014-01-21 |
2023-09-01 |
Janssen Pharmaceutica Nv |
Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
|
|
EP3331564B1
(en)
|
2015-08-07 |
2025-01-08 |
Imaginab, Inc. |
Antigen binding constructs to target molecules
|
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
AU2018256436B2
(en)
|
2017-04-19 |
2024-12-05 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|